openPR Logo
Press release

Herpes Markers Testing Market

06-15-2018 11:36 AM CET | Health & Medicine

Press release from: Persistence Market Research

According to the latest market report published by Persistence Market Research titled ‘Herpes Marker Testing Market: Global Industry Analysis (2012 – 2016) & Forecast (2017 – 2025)’, the global market is expected to be valued at US$ 481.8 Mn by 2025 and expand at a CAGR of 6.1% over the forecast period (2017–2025). The overall market is anticipated to grow 1.7x in terms of value over the forecast period.

Market Dynamics

Certain factors such as positive diagnostic lab industry dynamics, increasing herpes prevalence, rising awareness, support from various government and non-government organizations, new product approvals and launches, increasing focus on evidence based medicines etc. are boosting revenue growth of the market. However, insufficient R&D initiatives, poor access to diagnostic services in remote areas, pricing pressures, and stringent regulations are some of the factors restricting growth of the market.

Segmental Forecast

On the basis of test type, the market has been segmented into viral culture test, nucleic acid amplification-based kits and antibody/antigen-based kits. Antibody/Antigen based kits is the highest revenue generating segment over the forecast period owing to the huge product availability as well as high physician preference for this test type. Nucleic Acid Amplification-based kits segment will report the highest growth rate over the forecast period due to the growing acceptance of PCR diagnosis as a gold standard test in herpes testing owing to high sensitivity, specificity and positivity ratio for herpes diagnosis. Antibody/Antigen based kits is projected to be the most attractive segment with an attractiveness index of 1.5 during the forecast period.

Based on the indication, the market has been segmented into HSV-1, HSV-2 and HSV-1/ HSV-2. HSV-1/HSV-2 segment dominated the global herpes marker testing market in revenue terms in 2016 and is projected to continue to do so throughout the forecast period. HSV-1/HSV-2 is projected to be the most attractive segment with an attractiveness index of 1.6 and growth rate of 6.5% during the forecast period.

On the basis of application, the market has been segmented into research use and clinical diagnostics segment. Clinical diagnostics application dominates the market for herpes marker testing with a value share in excess of 85% throughout the forecast period.

Based on end user, the market has been segmented into hospitals, diagnostics centers, clinics and academic & research institutes. Among all the end users, most of the revenue is generated via the diagnostic centers sales followed by hospitals owing to the maximum number of tests being performed at these facilities. Diagnostics centers dominated the global herpes marker testing market in revenue terms in 2016 and is projected to continue to do so throughout the forecast period. This segment represents a market attractiveness index of 1.6 over the forecast period.

Among the regional markets, North America holds the maximum value share in the global market owing to the accessibility and affordability of diagnostic services in the region and a favorable reimbursement scenario. In terms of growth rate, North America leads with a CAGR of 6.4% followed by Asia Pacific with a CAGR of 6.3%. Asia Pacific represents a highly potential market with a significant growth rate owing to the increasing awareness as well as increasing penetration of market players in the region. The market in Europe ranks third in terms of global market size as well as growth rate while Latin America represents the least market attractiveness index over the forecast period.

Request Sample Report @ https://www.persistencemarketresearch.com/samples/4185

Vendor Insights

Leading players operating in the global herpes marker testing market covered in the report include Abbott Laboratories, Abcam Plc, BioMérieux SA, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., DiaSorin S.p.A., Quidel Corporation, Luminex Corporation, Merck KGaA, Qiagen N.V., Norgen Biotek Corp., Hologic Inc., Bio Rad Laboratories Inc., Meridian Bioscience Inc. and Teco Diagnostics.

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Herpes Markers Testing Market here

News-ID: 1084092 • Views: 360

More Releases from Persistence Market Research

Transformational Skincare Market to Stand Tall from 2020 to 2030
Transformational skincare involves practices that deal with supporting skin integrity, enhancing appearance, and also curing skin conditions. Skincare is a daily routine action in many settings, such as dealing with the type of skin, too dry skin or moist skin, prevention of incontinence-associated dermatitis and prevention of skin injuries. Transformational skincare covers nutrition, appropriate use of emollients, and avoidance of excessive sun exposure. There is a wide range of skincare
Increase in Frequency of Product Innovations to Drive the Small RNA Detection Ma …
Small RNA is a class of non-coding RNA that plays a major role in the regulation of gene expressions. Small RNA works at the post-transcription level and modify the expression of around 30% of all mammalian protein-encoding genes. Small RNA detection is performed to determine the role of small RNA, useful in the diagnosis and treatment of various diseases. The global small RNA detection market is likely to expand during
Coil Wound Devices Market is anticipated to touch a valuation of nearly US$ 119, …
Persistence Market Research presents a new report titled ‘Coil Wound Devices Market: Global Industry Analysis 2012 – 2016 and Forecast 2017 – 2025’ that studies the performance of the global coil wound devices market over an eight year assessment period from 2017 to 2025. The report presents the value and volume forecasts of the global coil wound devices market and provides important insights into the factors driving market growth as well
S1P receptor modulator Drugs Market To Witness a Major Overhaul between 2020 and …
S1P receptor performs basic biological processes such as cell proliferation, migration, cytoskeleton organization, immune cell trafficking and others. S1P receptor modulators are a type of immunomodulatory used in case of multiple sclerosis, psoriasis, inflammatory diseases, and cancer. S1P receptor modulators are used to control the release of lymphocytes in peripheral blood and reach the central nervous system. According to the Multiple Sclerosis Association of America, approximately 3.5 out of 1,000

All 5 Releases


More Releases for Bio

Global Bioplastics (Bio-plastics,Bio plastics) Market 2018 - Braskem, BASF
Apex Market Reports, recently published a detailed market research study focused on the “Bioplastics (Bio-plastics,Bio plastics) Market” across the global, regional and country level. The report provides 360° analysis of “Bioplastics (Bio-plastics,Bio plastics) Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Bioplastics
Bio Electronics and Bio Sensors Market Forecasts, 2017-2025
Description: The global bio electronic market is valued USD $15 billion in 2016 and is expected to grow at a CAGR of 11.6% during the forecast period 2017-2025. The market is driven by various factors such as rapid advancement in semiconductor technology, high demand in implantable medical devices, increasing prevalence of neural and cardiac diseases among others. The emerging healthcare technologies such as lab on chip, ambulatory surgical centres, and personalized devices are
Bio Simulation Technology Market
Global Bio Simulation Technology Industry Bio Simulation Technology Market is estimated at $1.01 billion in 2015 and is projected to reach $2.99 billion by 2022 growing at a CAGR of 16.6% from 2015 to 2022. Reduction in the cost of drug discovery and development and risk of failure of drug molecule are some of the factors driving the market growth. Furthermore, R&D investments in biotechnology and pharmaceutical industries, growth in the
Global Bio-Polyethylene Terephthalate (Bio-PET) Market Research Report 2021
Qyresearchreports include new market research report “Global Bio-Polyethylene Terephthalate (Bio-PET) Market Research Report 2021″ to its huge collection of research reports. This market intelligence report serves its readers with an executive-level blueprint of the global Bio-Polyethylene Terephthalate (Bio-PET) market. Data from a number of paid and unpaid sources including press releases, journals, presentations, and white papers has been taken into account for collating this report. The various factors influencing the growth of
SHANE RADBONE CORPORATE BIO
Young, dynamic and highly successful Shane founded his own business, Executive Fitness Management at age 20 in 1991. After a successful career in football that took him as high as playing for Essendon, Shane appreciated the need to have more than just sport in his portfolio. However taking his on field attitude to the corporate arena, Executive Fitness Management (EFM) grew into Australia’s largest Corporate Fitness Company. It started with
The Bio-Chromatographers’ wish
Simply high dynamic binding capacities (DBC’s) are no longer sufficient. High DBC, at high flow rates with close to 100% recovery, across a wide range of molecular weights, this is what chromatographers look for in modern ion exchange resins. “BioPro” YMC’s hugely successful ion exchange material offers exactly this. The growing user base confirms very good separation, high dynamic binding capacities and excellent recoveries for the anion as well as